Julie Hambleton, EVP & Chief Medical Officer at FIVE PRIME THERAPEUTICS INC (FPRX), sold 23,108 shares at $34.75 ($800K) on 2015-11-11, disclosed to the SEC on 2015-11-13.
Open-market sale of $800k FPRX by EVP & Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $34.33 | 12,000 | $412K | 51.5% |
| 2 | $34.75 | 6,600 | $229K | 28.7% |
| 3 | $35.23 | 3,400 | $120K | 15.0% |
| 4 | $35.33 | 1,108 | $39K | 4.9% |
| Total | $34.63 avg | 23,108 | $800K | 100% |
| Filing → |
| SWTX | SELL | 2024-06-05 | $302K | — | Filing → |
| SWTX | SELL | 2023-07-21 | $142K | — | Filing → |
| SWTX | SELL | 2023-06-22 | $129K | — | Filing → |